Insider trade

Cencora (COR): CEO sold ~$455K

Robert P. Mauch, CEO at Cencora, sold ~$455K of Cencora shares.

~$455K
Approx. value · 1,744 sh @ $260.93
49K
Holds after · shares reported
Traded
Mar 18, 2025
Filed
Mar 19, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Feb 6, 2025Insider · 1 personInsiders: 2 sales (~$314.5M)
  2. Feb 21, 2025InsiderOfficer sold ~$1.21M of COR shares in the open market
  3. Feb 27, 2025Insider · 1 personInsiders: 2 sales (~$3.7M)
  4. Mar 3, 2025Insider · 1 personInsiders: 2 sales (~$1.3M)
  5. Mar 10, 2025InsiderOfficer sold ~$520K of COR shares in the open market
  6. Mar 18, 2025 · this disclosureInsiderCEO sold ~$455K of COR shares in the open market

What came next

  1. Mar 18, 2025InsiderCEO sold ~$842K of COR shares in the open market
  2. Mar 24, 2025FDARecall: Voriconazole Tablets, 50 mg, packaged in cartons of 3 blister cards with 10 individual blistered doses (30 Unit Dose per carton), Rx only, Distributed by: Amer…
  3. Mar 24, 2025Insider · 1 personInsiders: 2 sales (~$1.1M)
  4. Mar 25, 2025Insider · 1 personInsiders: 2 sales (~$3.9M)
  5. Mar 27, 2025CongressDisclosed sale of COR — reported range $15,001 - $50,000
  6. Apr 2, 2025FDARecall: Haloperidol Decanoate Injection, 100 mg/mL*, 1 x 1 mL Single-Dose Vial, Rx only, Manufactured by: Somerset Therapeutics Limited, #54/1, Boodhihal Village, Nela…
  7. Apr 2, 2025FDARecall: Haloperidol Decanoate Injection, 100mg/mL*, 5 x 1 mL Single-Dose Vials, Rx Only, Manufactured by: Somerset Therapeutics Limited, #54/1 Boodhihal Village, Nelam…
  8. Apr 2, 2025FDARecall: Haloperidol Decanoate Injection, 50mg/mL* , 1 mL Single-Dose Vial, Rx only, Manufactured by Somerset Therapeutics Limited, 54/1, Boodhihal Village, Nelamangala…
  9. Apr 21, 2025InsiderCEO sold ~$1.44M of COR shares in the open market
  10. Apr 22, 2025InsiderChair sold ~$4.11M of COR shares in the open market
  11. May 12, 2025CongressDisclosed sale of COR — reported range $50,001 - $100,000
  12. May 14, 2025InsiderDirector sold ~$837K of COR shares in the open market
  13. May 15, 2025FDARecall: Indomethacin Extended-Release Capsules, USP, 75 mg, 30 capsules (3 x 10 blister cards) per carton, Rx Only, Distributed by: American Health Packaging, Columbus…
  14. May 19, 2025InsiderCEO sold ~$1.45M of COR shares in the open market
  15. May 20, 2025InsiderChair sold ~$4.28M of COR shares in the open market
  16. May 29, 2025Insider · 1 personInsiders: 2 sales (~$867K)
  17. Jun 18, 2025Insider · 2 peopleInsiders: 2 sales (~$2.7M)
  18. Jun 24, 2025InsiderChair sold ~$4.27M of COR shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cencora

For Cencora, OQRO holds 8 insider filings (SEC Form 4 or Form 144), 1 fund holdings report (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its COR page.

Other recent filings by Robert P. Mauch, President & CEO

The full history of Robert P. Mauch, President & CEO is on the profile page.

How this filing works

Explore the data

Common questions

Which Cencora (COR) insider traded, and how much?

Robert P. Mauch, CEO at Cencora, sold ~$455K of Cencora shares. 1,744 shares at $260.93.

When did it happen, and when was it made public?

Traded: Mar 18, 2025. Filed: Mar 19, 2025. That is 1 day between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Cencora recently?

For Cencora, OQRO holds 8 insider filings (SEC Form 4 or Form 144), 1 fund holdings report (13F) and 1 federal contract award dated in the last 90 days. They are listed on the COR page.

Does this mean COR stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Cencora

Everything OQRO holds on this company is on its COR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data